The DOI matches its Crossref record; 129 of the 129 references it cites were found in a registry or an index.
Antithyroid Drugs
Abstract
Antithyroid drugs, which have been available for more than half a century, are important in the management of hyperthyroidism, particularly in patients with Graves' disease, who have a high response rate. Since the responses of patients vary and these agents have potentially serious side effects, a working knowledge of their complex pharmacology is required. This review article considers recent pharmacologic and clinical data related to the use of these compounds.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Some patients may develop a transient increase in thyroid hormones after RAI [115, 117] .”
From The 2015 European Thyroid Association Guidelines on Diagnosis and Treatment of Endogenous Subclinical Hyperthyroidism (2015) · cites this paper as [115]
In the citing paper
“ATDs are associated with a variety of side effects that include rare but potentially life-threatening complications [4,115,116] .”
From The 2015 European Thyroid Association Guidelines on Diagnosis and Treatment of Endogenous Subclinical Hyperthyroidism (2015) · cites this paper as [115]
In the citing paper
“Hepatocellular disease is rarely reported during MMI treatment [115, 117] .”
From The 2015 European Thyroid Association Guidelines on Diagnosis and Treatment of Endogenous Subclinical Hyperthyroidism (2015) · cites this paper as [115]
In the citing paper
“However, this approach is not generally recommended because it has been shown to result in a higher rate of ATD side effects (109,119).”
From 2016 American Thyroid Association Guidelines for Diagnosis and Management of Hyperthyroidism and Other Causes of Thyrotoxicosis (2016) · cites this paper as [109]
In the citing paper
“since remission rates are highest in persons with mild disease (109).”
From 2016 American Thyroid Association Guidelines for Diagnosis and Management of Hyperthyroidism and Other Causes of Thyrotoxicosis (2016) · cites this paper as [109]
In the citing paper
“MMI and PTU both appear in breast milk in only small concentrations, and studies of breastfed infants of mothers taking ATDs have demonstrated normal thyroid function and subsequent normal intellectual development (109).”
From 2016 American Thyroid Association Guidelines for Diagnosis and Management of Hyperthyroidism and Other Causes of Thyrotoxicosis (2016) · cites this paper as [109]
In the citing paper
“Both MMI and PTU are effective therapies of hyperthyroidism in the majority of patients, and the major effect of both drugs is interaction with thyroid peroxidase-catalyzed thyroid hormone production (109).”
From 2016 American Thyroid Association Guidelines for Diagnosis and Management of Hyperthyroidism and Other Causes of Thyrotoxicosis (2016) · cites this paper as [109]
Citations
Cites
The Transfer of Drugs and Other Chemicals Into Human Milk
Committee on Drugs (2001) · Pediatrics · doi:10.1542/peds.108.3.776 · Cited by 1,256
Occurrence of Ophthalmopathy after Treatment for Graves' Hyperthyroidism
Tallstedt, L., Lundell, G., Tørring, O., Wallin, G., Ljunggren, J.-G., Blomgren, H., & Taube, A. (1992) · New England Journal of Medicine · doi:10.1056/nejm199206253262603 · Cited by 521
Treatment Guidelines for Patients With Hyperthyroidism and Hypothyroidism
Singer, P. A. (1995) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1995.03520340064038 · Cited by 427
Liver transplantation for acute liver failure from drug induced liver injury in the United States
Russo, M. W., Galanko, J. A., Shrestha, R., Fried, M. W., & Watkins, P. (2004) · Liver Transplantation · doi:10.1002/lt.20204 · Cited by 393
Wartofsky, L., Glinoer, D., Solomon, B. L., Nagataki, S., Lagasse, R., Nagayama, Y., & Izumi, M. (1991) · Thyroid · doi:10.1089/thy.1991.1.129 · Cited by 374
Cooper, D. S. (1984) · New England Journal of Medicine · doi:10.1056/nejm198411223112106 · Cited by 323
Self-citationTörring, O., Tallstedt, L., Wallin, G., Lundell, G. E. F., Ljunggren, J. ‐., Taube, A., Sääf, M., & Hamberger, B. (1996) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.81.8.8768863 · Cited by 311
VITTI, P., RAGO, T., CHIOVATO, L., PALLINI, S., SANTINI, F., FIORE, E., ROCCHI, R., MARTINO, E., & PINCHERA, A. (1997) · Thyroid · doi:10.1089/thy.1997.7.369 · Cited by 293
Carbimazole and the Autoimmune Response in Graves' Disease
McGregor, A. M., Petersen, M. M., McLachlan, S. M., Rooke, P., Smith, B. R., & Hall, R. (1980) · New England Journal of Medicine · doi:10.1056/nejm198008073030603 · Cited by 274
Current Trends in the Management of Graves' Disease*
Solomon, B. L., Glinoer, D., Lagasse, R., & Wartofsky, L. (1990) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-70-6-1518 · Cited by 266
Flagged first, then by citations
Research works printed but not linked: 18
- Taurog A. Hormone synthesis and secretion. In: Braverman LE, Utiger RD, eds. Werner and Ingbar's the thyroid: a fundamental and clinical text. Philadelphia: Lippincott-Raven, 1996:47-80.
- 10.1210/jc.81.8.2976 · DOI
- Wilson R, 1988, Clin Exp Immunol, 73, 312
- 10.1001/archinte.147.4.785 · DOI
- 10.1210/jc.81.8.2986 · DOI
- 10.1210/jc.86.8.3488 · DOI
- 10.1210/jc.76.6.1516 · DOI
- 10.1210/jc.80.8.2470 · DOI
- Abraham P, 2004, Cochrane Database Syst Rev, 2, CD003420
- 10.1210/jc.81.9.3283 · DOI
- Ducornet B, 1988, Ann Med Interne (Paris), 139, 410
- 10.1210/jc.82.6.1727 · DOI
- Parker WA, 1982, Clin Pharm, 1, 471
- 10.1210/jc.84.1.13 · DOI
- Waldhauser L, 1991, Drug Metab Dispos, 19, 354
- 10.1210/jc.85.11.4270 · DOI · Paper page
- 10.1210/jc.82.9.3099 · DOI
- Junik R, 1989, Endokrynol Pol, 40, 307
Cited by
Sorted by citations
Items 101–200 of 1,002
Approach to the Pediatric Patient with Graves' Disease: When Is Definitive Therapy Warranted?
Bauer, A. J. (2011) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2010-0898 · Cited by 66
Balavoine, A.-S., Glinoer, D., Dubucquoi, S., & Wémeau, J.-L. (2015) · Thyroid® · doi:10.1089/thy.2014.0603 · Cited by 65
An insight into the medicinal perspective of synthetic analogs of imidazole
Rulhania, S., Kumar, S., Nehra, B., Gupta, G. D., & Monga, V. (2021) · Journal of Molecular Structure · doi:10.1016/j.molstruc.2021.129982 · Cited by 65
Léger, J., Kaguelidou, F., Alberti, C., & Carel, J. (2013) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2013.08.008 · Cited by 65
Landry, V. K., Minoura, M., Pang, K., Buccella, D., Kelly, B. V., & Parkin, G. (2006) · Journal of the American Chemical Society · doi:10.1021/ja063168e · Cited by 65
Triclosan interferes with the thyroid axis in the zebrafish (Danio rerio)
Pinto, P. I. S., Guerreiro, E. M., & Power, D. M. (2012) · Toxicology Research · doi:10.1039/c2tx20005h · Cited by 65
Gao, Y., Chen, M., Ye, H., Yu, F., Guo, X.-H., & Zhao, M.-H. (2008) · Rheumatology · doi:10.1093/rheumatology/ken321 · Cited by 64
Adverse Events Associated with Methimazole Therapy of Graves' Disease in Children
Rivkees, S., Stephenson, K., & Dinauer, C. (2010) · International Journal of Pediatric Endocrinology · doi:10.1186/1687-9856-2010-176970 · Cited by 63
Kimani, M. M., Brumaghim, J. L., & VanDerveer, D. G. (2010) · Inorganic Chemistry · doi:10.1021/ic100668b · Cited by 63
Schmidt, F., & Braunbeck, T. A. (2011) · Journal of Thyroid Research · doi:10.4061/2011/376243 · Cited by 61
Analysis of 90 Cases of Antithyroid Drug-Induced Severe Hepatotoxicity Over 13 Years in China
Yang, J., Li, L.-F., Xu, Q., Zhang, J., Weng, W.-W., Zhu, Y.-J., & Dong, M.-J. (2015) · Thyroid · doi:10.1089/thy.2014.0350 · Cited by 60
Thyroid diseases increased the risk of type 2 diabetes mellitus: A nation-wide cohort study
Chen, R.-H., Chen, H.-Y., Man, K.-M., Chen, S.-J., Chen, W., Liu, P.-L., Chen, Y.-H., & Chen, W.-C. (2019) · Medicine · doi:10.1097/md.0000000000015631 · Cited by 59
Preconception management of thyroid dysfunction
Okosieme, O. E., Khan, I., & Taylor, P. N. (2018) · Clinical Endocrinology · doi:10.1111/cen.13731 · Cited by 59
Determination of oxidative stress in thyroid tissue and plasma of patients with Graves' disease
Ademoğlu, E., Özbey, N., Erbil, Y., Tanrıkulu-Küçük, S., Barbaros, U., Yanık, B. T., Bozbora, A., & Özarmağan, S. (2006) · European Journal of Internal Medicine · doi:10.1016/j.ejim.2006.04.013 · Cited by 59
Glinoer, D., & Cooper, D. S. (2012) · Current Opinion in Endocrinology Diabetes and Obesity · doi:10.1097/med.0b013e3283565b49 · Cited by 59
Self-citationMaia, A. L., Scheffel, R. S., Meyer, E. L. D. S., Mazeto, G. M. F. D. S., de Carvalho, G. A., Graf, H., Vaisman, M., Maciel, L. M. Z., Ramos, H. E., Tincani, Á. J., et al. (2013) · Arquivos Brasileiros de Endocrinologia & Metabologia · doi:10.1590/s0004-27302013000300006 · Cited by 62
Vallortigara, J., Alfos, S., Micheau, J., Higueret, P., & Enderlin, V. (2008) · Neurobiology of Disease · doi:10.1016/j.nbd.2008.05.015 · Cited by 58
Ruggeri, R. B., Buckbinder, L., Bagley, S. W., Carpino, P. A., Conn, E. L., Dowling, M., Fernando, D. P., Jiao, W., Kung, D. W., Orr, S. T. M., et al. (2015) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.5b00963 · Cited by 58
Chi, Y., Duan, J., Lin, S., & Chen, G. (2006) · Analytical Chemistry · doi:10.1021/ac051508t · Cited by 58
Current and emerging treatment options for Graves’ hyperthyroidism
Abraham, P., & Acharya (2009) · Therapeutics and Clinical Risk Management · doi:10.2147/tcrm.s5229 · Cited by 57
Léger, J., & Carel, J. (2017) · European Journal of Endocrinology · doi:10.1530/eje-16-0938 · Cited by 57
Novel thyroid hormone analogues, enzyme inhibitors and mimetics, and their action
Mondal, S., & Mugesh, G. (2017) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2017.04.006 · Cited by 58
Diagnosis and management of hyperthyroidism from prenatal life to adolescence
Léger, J., & Carel, J. (2018) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2018.03.014 · Cited by 57
Medical management of thyroid dysfunction in pregnancy and the postpartum
Okosieme, O. E., Marx, H., & Lazarus, J. H. (2008) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.9.13.2281 · Cited by 57
Dalmazi, G. D., & Giuliani, C. (2021) · Food and Chemical Toxicology · doi:10.1016/j.fct.2021.112158 · Cited by 55
Bhabak, K. P., & Mugesh, G. (2009) · Chemistry - A European Journal · doi:10.1002/chem.200902145 · Cited by 55
Kimani, M. M., Wang, H. C., & Brumaghim, J. L. (2012) · Dalton Transactions · doi:10.1039/c2dt11731b · Cited by 54
Guidelines for the treatment of childhood-onset Graves’ disease in Japan, 2016
Minamitani, K., Sato, H., Ohye, H., Harada, S., & Arisaka, O. (2017) · Clinical Pediatric Endocrinology · doi:10.1297/cpe.26.29 · Cited by 54
Ishitobi, H., MORI, K., Yoshida, K., & Watanabe, C. (2007) · NeuroToxicology · doi:10.1016/j.neuro.2007.02.007 · Cited by 54
Leow, M. K.-S. (2007) · Journal of Theoretical Biology · doi:10.1016/j.jtbi.2007.05.016 · Cited by 53
Blocking type TSH receptor antibodies
Furmaniak, J., Sanders, J. F., & Smith, B. R. (2012) · Autoimmunity Highlights · doi:10.1007/s13317-012-0028-1 · Cited by 53
Photoelectron spectra of 2-thiouracil, 4-thiouracil, and 2,4-dithiouracil
Ruckenbauer, M., Mai, S., Marquetand, P., & González, L. (2016) · The Journal of Chemical Physics · doi:10.1063/1.4941948 · Cited by 53
Yang, J. J., Zhu, Y., Zhong, J., Zhang, J., Weng, W.-W., Liu, Z.-F., Xu, Q., & Dong, M. (2016) · Thyroid · doi:10.1089/thy.2015.0439 · Cited by 53
Myeloperoxidase: a potential therapeutic target for coronary artery disease
Chaikijurajai, T., & Tang, W. H. W. (2020) · Expert Opinion on Therapeutic Targets · doi:10.1080/14728222.2020.1762177 · Cited by 53
Nayak, B. M., & Hodak, S. P. (2007) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2007.06.002 · Cited by 54
Pradeep, P. V., Agarwal, A., Baxi, M., Agarwal, G., Gupta, S. K., & Mishra, S. K. (2007) · World Journal of Surgery · doi:10.1007/s00268-006-0572-9 · Cited by 53
Metso, S., Auvinen, A. P., Salmi, J., Huhtala, H., & Jaatinen, P. (2007) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2007.03064.x · Cited by 52
B-cell depletion with rituximab in the treatment of autoimmune diseases
Nielsen, C. H., Fassi, D. E., Hasselbalch, H. C., Bendtzen, K., & Hegedűs, L. D. (2007) · Expert Opinion on Biological Therapy · doi:10.1517/14712598.7.7.1061 · Cited by 52
Drug-induced anti-neutrophil cytoplasmic antibody-associated vasculitis
Weng, C., & Liu, Z. (2019) · Chinese Medical Journal · doi:10.1097/cm9.0000000000000539 · Cited by 52
Propylthiouracil Versus Methimazole in Treatment of Graves' Disease During Pregnancy
Chattaway, J. M., & Klepser, T. B. (2007) · Annals of Pharmacotherapy · doi:10.1345/aph.1h535 · Cited by 52
Lo, J. C., Rivkees, S. A., Chandra, M., Gonzalez, J. R., Korelitz, J. J., & Kuzniewicz, M. W. (2015) · Thyroid® · doi:10.1089/thy.2014.0434 · Cited by 51
Effects of the anti-thyroidal compound potassium-perchlorate on the thyroid system of the zebrafish
Schmidt, F., Schnurr, S. M., Wolf, R. L., & Braunbeck, T. A. (2011) · Aquatic Toxicology · doi:10.1016/j.aquatox.2011.11.004 · Cited by 51
Friedman, K. P., Hedge, J. M., Macherla, C., Filer, D. L., Burgess, E., Simmons, S. O., Crofton, K. M., & Hornung, M. W. (2013) · Toxicology · doi:10.1016/j.tox.2013.08.006 · Cited by 51
Bonnema, S. J., Bennedbæk, F. N., Veje, A., Marving, J., & Hegedűs, L. D. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-0226 · Cited by 51
The Cost Effectiveness of Treatment Modalities for Thyrotoxicosis in a U.K. Center
Patel, N., Abraham, P., Buscombe, J. R., & Vanderpump, M. P. J. (2006) · Thyroid · doi:10.1089/thy.2006.16.593 · Cited by 51
Characterization of the anaemia associated with Graves’ disease
Gianoukakis, A. G., Leigh, M. J., Richards, P. G., Christenson, P. D., Hakimian, A., Fu, P. C., Niihara, Y., & Smith, T. J. (2008) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2008.03382.x · Cited by 51
The safety and efficacy of antithyroid drugs
Azizi, F. (2005) · Expert Opinion on Drug Safety · doi:10.1517/14740338.5.1.107 · Cited by 52
Walter, M. A., Christ-Crain, M., Schindler, C., Müller-Brand, J., & Müller, B. (2006) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-006-0092-8 · Cited by 49
Quercetin alleviates hyperthyroidism‐induced liver damage via Nrf2 Signaling pathway
Zhao, P., Hu, Z., Ma, W., Zang, L., Tian, Z., & Hou, Q. (2020) · BioFactors · doi:10.1002/biof.1626 · Cited by 49
Lionaki, S., Jennette, J. C., & Falk, R. J. (2007) · Seminars in Immunopathology · doi:10.1007/s00281-007-0093-0 · Cited by 48
Nonchemotherapy Drug-Induced Neutropenia and Agranulocytosis
Pick, A. M., & Nystrom, K. K. (2014) · Journal of Pharmacy Practice · doi:10.1177/0897190014546115 · Cited by 48
Carlé, A., Andersen, S. L., Boelaert, K., & Laurberg, P. (2017) · European Journal of Endocrinology · doi:10.1530/eje-16-0276 · Cited by 51
Antithyroid Drug Therapy for Graves’ Disease and Implications for Recurrence
Liu, J., Fu, J. H., Xu, Y., & Wang, G. (2017) · International Journal of Endocrinology · doi:10.1155/2017/3813540 · Cited by 48
Ibrahim, W., Tousson, E., Ali, E. M. M., & Mansour, M. A. (2011) · General and Comparative Endocrinology · doi:10.1016/j.ygcen.2011.08.012 · Cited by 48
Selenium Analogues of Antithyroid Drugs – Recent Developments
Roy, G., & Mugesh, G. (2008) · Chemistry & Biodiversity · doi:10.1002/cbdv.200890042 · Cited by 47
Paradoxical effect of methimazole on liver mitochondria: In vitro and in vivo
Niknahad, H., Jamshidzadeh, A., Heidari, R., Hosseini, Z., Mobini, K., Khodaei, F., Ommati, M. M., Abdoli, N., Keshavarz, N., Bazyari, M., et al. (2016) · Toxicology Letters · doi:10.1016/j.toxlet.2016.08.003 · Cited by 47
Suzuki, N., Noh, J. Y., Hiruma, M., Kawaguchi, A., Morisaki, M., Ohye, H., Suzuki, M., Matsumoto, M., Kunii, Y., Iwaku, K., et al. (2019) · Thyroid · doi:10.1089/thy.2019.0045 · Cited by 47
Pediatric Graves’ disease: management in the post-propylthiouracil Era
Rivkees, S. A. (2014) · International Journal of Pediatric Endocrinology · doi:10.1186/1687-9856-2014-10 · Cited by 46
Uchida, T., Goto, H., Kasai, T., Komiya, K., Takeno, K., Abe, H., Shigihara, N., Sato, J., Honda, A., Mita, T., et al. (2014) · Endocrine · doi:10.1007/s12020-014-0171-8 · Cited by 46
Stadelman, B. S., Kimani, M. M., Bayse, C. A., McMillen, C. D., & Brumaghim, J. L. (2016) · Dalton Transactions · doi:10.1039/c5dt03384e · Cited by 46
Shi, H., Sheng, R., Hu, Y., Liu, X., Jiang, L., Wang, Z., & Cui, D. (2020) · Clinical Therapeutics · doi:10.1016/j.clinthera.2020.01.022 · Cited by 46
Yu, C., Qin, D., Jiang, X., Zheng, X., & Deng, B. (2021) · Microchemical Journal · doi:10.1016/j.microc.2021.106480 · Cited by 46
Kobayashi, S., Noh, J. Y., Mukasa, K., Kunii, Y., Watanabe, N., Matsumoto, M., Ohye, H., Suzuki, M., Yoshihara, A., Iwaku, K., et al. (2014) · Thyroid® · doi:10.1089/thy.2013.0476 · Cited by 45
OECD (2014) · OECD series on testing and assessment · doi:10.1787/9789264274716-en · Cited by 45
Raldúa, D., Thienpont, B., & Babin, P. J. (2011) · Reproductive Toxicology · doi:10.1016/j.reprotox.2011.09.001 · Cited by 45
Higher thyroid hormone levels and cancer
Ovčariček, P. P., Verburg, F. A., Hoffmann, M., Iakovou, I. P., Mihailovic, J. M., Vrachimis, A., Luster, M., & Giovanella, L. (2020) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-020-05018-z · Cited by 45
Antithyroid Drug-Induced Aplastic Anemia
Thomas, D., Moisidis, A., Tsiakalos, A., Alexandraki, K., Syriou, V., & Kaltsas, G. (2008) · Thyroid · doi:10.1089/thy.2008.0097 · Cited by 44
Predicting relapse of Graves' disease following treatment with antithyroid drugs
Liu, L., Lu, H.-W., Liu, Y., Liu, C., & Chu, X. (2016) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2016.3058 · Cited by 44
Structural Characterization of 2-Imidazolones: Comparison with their Heavier Chalcogen Counterparts
Rong, Y., Alharbi, A., Kriegel, B. M., & Parkin, G. (2013) · Inorganic Chemistry · doi:10.1021/ic400788g · Cited by 44
Tamilselvi, A., & Mugesh, G. (2010) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2010.04.087 · Cited by 44
Thymic hyperplasia in patients with Graves’ disease
Costa, M. D., Mangano, F., & Betterle, C. (2014) · Journal of Endocrinological Investigation · doi:10.1007/s40618-014-0157-7 · Cited by 44
Novel indolyl-pyrimidine derivatives: synthesis, antimicrobial, and antioxidant evaluations
Mohamed, M. S., Youns, M., & Ahmed, N. M. (2014) · Medicinal Chemistry Research · doi:10.1007/s00044-014-0916-1 · Cited by 44
Management of Subclinical Hyperthyroidism
Palacios, S. S., Corrales, E. P., & Galofré, J. C. (2012) · Intern J Endocrinol Metab · doi:10.5812/ijem.3447 · Cited by 44
Palmer, J. H., & Parkin, G. (2015) · Journal of the American Chemical Society · doi:10.1021/jacs.5b00840 · Cited by 42
Reinwald, H., Kardgar, A. K., Ayobahan, S. U., Alvincz, J., Şipoş, L., Göckener, B., Böhle, G., Shomroni, O., Hollert, H., Salinas, G., et al. (2020) · The Science of The Total Environment · doi:10.1016/j.scitotenv.2020.143914 · Cited by 42
Sahlmann, C. O., Homayounfar, K., Niessner, M., Dyczkowski, J., Conradi, L., Braulke, F., Meller, B., Beißbarth, T., Ghadimi, Β. M., Meller, J., et al. (2016) · Cancer · doi:10.1002/cncr.30390 · Cited by 41
Maternal hyperthyroidism and pregnancy outcomes: A population‐based cohort study
Turunen, S., Vääräsmäki, M., Lahesmaa‐Korpinen, A., Leinonen, M. K., Gissler, M., Männistö, T. I., & Suvanto, E. T. J. (2020) · Clinical Endocrinology · doi:10.1111/cen.14282 · Cited by 41
Parsa, A. A., & Bhangoo, A. (2013) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-013-9248-6 · Cited by 41
The target antigens of antineutrophil cytoplasmic antibodies (ANCA) induced by propylthiouracil
Gao, Y., Chen, M., Ye, H., Guo, X.-H., Zhao, M.-H., & Wang, H.-Y. (2007) · International Immunopharmacology · doi:10.1016/j.intimp.2006.07.033 · Cited by 40
An update on the medical treatment of Graves’ hyperthyroidism
Marinò, M., Latrofa, F., Menconi, F., Chiovato, L., & Vitti, P. (2014) · Journal of Endocrinological Investigation · doi:10.1007/s40618-014-0136-z · Cited by 40
Kwon, H., Kim, W. G., Jang, E. K., Kim, M., Park, S., Jeon, M. J., Kim, T. Y., Ryu, J., Shong, Y. K., & Kim, W. B. (2016) · Endocrinology and Metabolism · doi:10.3803/enm.2016.31.2.300 · Cited by 40
Decallonne, B., Bartholome, E. J., Delvaux, V., D’haeseleer, M., Sankari, S. E., Seeldrayers, P., Wijmeersch, B. V., & Daumerie, C. (2018) · Acta Neurologica Belgica · doi:10.1007/s13760-018-0883-2 · Cited by 41
Synthesis, structure and reactivity of 4-phosphanylated 1,3-dialkyl-imidazole-2-thiones
Sauerbrey, S., Majhi, P. K., Schnakenburg, G., Arduengo, A. J., & Streubel, R. (2012) · Dalton Transactions · doi:10.1039/c2dt12483a · Cited by 39
Synthesis and rearrangement of a bridged thioamide
Szostak, M., & Aubé, J. (2009) · Chemical Communications · doi:10.1039/b917508c · Cited by 39
Roy, G., & Mugesh, G. (2006) · Bioinorganic Chemistry and Applications · doi:10.1155/bca/2006/23214 · Cited by 39
Concomitant Agranulocytosis and Hepatotoxicity After Treatment with Carbimazole
Vilchez, F. J. G., Torres, I., García-Valero, A., López‐Tinoco, C., Moreno, A. D. L. S., & Aguilar‐Diosdado, M. (2006) · Annals of Pharmacotherapy · doi:10.1345/aph.1g720 · Cited by 38
Aversa, T., Corrias, A., Salerno, M., Tessaris, D., Mase, R. D., Valenzise, M., Corica, D., Luca, F. D., & Wasniewska, M. G. (2016) · Thyroid · doi:10.1089/thy.2016.0080 · Cited by 38
Predictive factors of radioiodine therapy failure in Graves’ Disease: A meta-analysis
Shalaby, M., Hadedeya, D., Toraih, E. A., Razavi, M. A., Lee, G. S., Hussein, M. H., Weidenhaft, M. C., Serou, M. J., Ibraheem, K., Abdelgawad, M., et al. (2021) · The American Journal of Surgery · doi:10.1016/j.amjsurg.2021.03.068 · Cited by 37
Awad, S. M., Zohny, Y. M., Ali, S. A., Mahgoub, S., & Said, A. M. (2018) · Molecules · doi:10.3390/molecules23112913 · Cited by 38
Enzymatic Thioamide Formation in a Bacterial Antimetabolite Pathway
Litomska, A., Ishida, K., Dunbar, K. L., Boettger, M., Coyne, S., & Hertweck, C. (2018) · Angewandte Chemie International Edition · doi:10.1002/anie.201804158 · Cited by 36
The treatment of Graves' disease in children and adolescents
Lee, H. S., & Hwang, J. S. (2014) · Annals of Pediatric Endocrinology & Metabolism · doi:10.6065/apem.2014.19.3.122 · Cited by 36
Kim, H. J., Bang, J.-I., Kim, J.-Y., Moon, J. H., So, Y., & Lee, W. W. (2017) · Korean Journal of Radiology · doi:10.3348/kjr.2017.18.3.543 · Cited by 36
Cai, H., Wang, Z., Zhang, H., Wang, F., Yu, C., Zhang, F., Gao, L., Zhang, J., & Zhao, J. (2013) · Acta Pharmacologica Sinica · doi:10.1038/aps.2013.133 · Cited by 36
A volumetric analysis of the brain and hippocampus of rats rendered perinatal hypothyroid
Hasegawa, M., Kida, I., & Wada, H. (2010) · Neuroscience Letters · doi:10.1016/j.neulet.2010.05.070 · Cited by 35
Nonthionamide Drugs for the Treatment of Hyperthyroidism: From Present to Future
Suwansaksri, N., Preechasuk, L., & Kunavisarut, T. (2018) · International Journal of Endocrinology · doi:10.1155/2018/5794054 · Cited by 35
Treatment of adult Graves’ disease
Corvilain, B., Hamy, A., Brunaud, L., Borson‐Chazot, F., Orgiazzi, J., Hachmi, L. B. S., Semrouni, M., Rodien, P., & Lussey‐Lepoutre, C. (2018) · Annales d Endocrinologie · doi:10.1016/j.ando.2018.08.003 · Cited by 36
Mai, S., Mohamadzade, A., Marquetand, P., González, L., & Ullrich, S. (2018) · Molecules · doi:10.3390/molecules23112836 · Cited by 35
Acute Pancreatitis Induced by Methimazole in a Patient with Graves' Disease
Yang, M., Qu, H., & Deng, H. (2011) · Thyroid · doi:10.1089/thy.2011.0210 · Cited by 35
Bhatti, M. T., & Dutton, J. J. (2014) · Journal of Neuro-Ophthalmology · doi:10.1097/wno.0000000000000128 · Cited by 35
McDermott, M. T. (2020) · Annals of Internal Medicine · doi:10.7326/aitc202004070 · Cited by 35
Metadata
- Authors
- Cooper, D. S.
- Affiliations
- Johns Hopkins University (US)
- Corresponding author
- Cooper, David S.
- ORCID
- Cooper, David S.
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2005-03-03
- Volume
- 352
- Issue
- 9
- Pages
- 905-917
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W4243225672
- Cited by
- 1,008
- References
- 123
- Citations by year
- 2026: 35 · 2025: 36 · 2024: 51 · 2023: 50 · 2022: 45 · 2021: 52 · 2020: 62 · 2019: 38 · 2018: 62 · 2017: 51 · 2016: 66 · 2015: 51 · 2014: 48 · 2013: 56 · 2012: 49
- FWCI
- 4.48
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- New England Journal of Medicine (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Thyroid Disorders and Treatments
- Health Sciences › Medicine › Surgery › Thyroid and Parathyroid Surgery
- Health Sciences › Medicine › Ophthalmology › Ophthalmology and Eye Disorders
- Keywords
- antithyroid drugs, hyperthyroidism, Graves' disease, adverse effects, drug response
- MeSH terms
- Agranulocytosis, Algorithms, Female, Graves Disease, Humans, Hyperthyroidism, Methimazole, Pregnancy, Pregnancy Complications, Propylthiouracil, Antithyroid Agents, Thyroid Gland, Thyrotoxicosis, Thyroxine, Triiodothyronine
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review